Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-Glutamine is an amino acid that plays a crucial role in various metabolic pathways, particularly D-glutamine and D-glutamate metabolism. Its involvement in these pathways has been implicated in a range of physiological and pathological conditions, including metabolic disorders, neurological conditions, and inflammatory responses. Research suggests its potential as a biomarker and its participation in the pathogenesis of diseases such as type 2 diabetes, colorectal cancer, major depressive disorder, and rheumatic heart disease. As a metabolite, D-Glutamine is a fundamental component of cellular processes and can be influenced by dietary interventions and environmental factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on D-Glutamine.